Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
May, 7 2026
Sep, 11 2025
Oct, 6 2025
Jun, 5 2025
Jun, 18 2026